These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 21826080

  • 1. Management of hepatorenal syndrome in patients with cirrhosis.
    Arroyo V, Fernández J.
    Nat Rev Nephrol; 2011 Aug 09; 7(9):517-26. PubMed ID: 21826080
    [Abstract] [Full Text] [Related]

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Aug 09; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 3. [Hepatorenal syndrome].
    Huschak G, Kaisers UX, Laudi S.
    Anaesthesist; 2013 Jul 09; 62(7):571-82. PubMed ID: 23846211
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B, Sardo L, Gigante A, Gasperini ML, Liberatori M, Giraldi GD, Lacanna A, Amoroso A, Cianci R.
    Curr Vasc Pharmacol; 2014 Jan 09; 12(1):125-35. PubMed ID: 24678726
    [Abstract] [Full Text] [Related]

  • 5. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V, Rodrigues SG, Stirnimann G, Gottardi A, Bosch J, Berzigotti A.
    United European Gastroenterol J; 2020 Oct 09; 8(8):961-969. PubMed ID: 32588789
    [Abstract] [Full Text] [Related]

  • 6. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V.
    Aliment Pharmacol Ther; 2004 Sep 09; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [Abstract] [Full Text] [Related]

  • 7. Management of ascites and hepatorenal syndrome.
    Piano S, Tonon M, Angeli P.
    Hepatol Int; 2018 Feb 09; 12(Suppl 1):122-134. PubMed ID: 28836115
    [Abstract] [Full Text] [Related]

  • 8. Hepatorenal syndrome.
    Ginès P, Guevara M, Arroyo V, Rodés J.
    Lancet; 2003 Nov 29; 362(9398):1819-27. PubMed ID: 14654322
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis and treatment of hepatorenal syndrome.
    Arroyo V, Fernandez J, Ginès P.
    Semin Liver Dis; 2008 Feb 29; 28(1):81-95. PubMed ID: 18293279
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A, Ginès P.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun 29; 3(6):338-48. PubMed ID: 16741553
    [Abstract] [Full Text] [Related]

  • 13. [Hepatorenal syndrome].
    Ben Chaabane N, Melki W, Hellara O, Safer L, Bdioui F, Saffar H.
    Tunis Med; 2011 Dec 29; 89(12):885-90. PubMed ID: 22198887
    [Abstract] [Full Text] [Related]

  • 14. [Renal impairment in liver diseases].
    Gerbes AL, Gülberg V.
    Praxis (Bern 1994); 2006 Oct 04; 95(40):1535-8. PubMed ID: 17048410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Hepatorenal syndrome].
    Baccaro ME, Guevara M.
    Gastroenterol Hepatol; 2007 Nov 04; 30(9):548-54. PubMed ID: 17980134
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Hepatorenal syndrome].
    Radziszewski A, Sułowicz W.
    Przegl Lek; 2006 Nov 04; 63(7):573-8. PubMed ID: 17203812
    [Abstract] [Full Text] [Related]

  • 20. Hepatorenal Disorders.
    Al-Khafaji A, Nadim MK, Kellum JA.
    Chest; 2015 Aug 04; 148(2):550-558. PubMed ID: 25811649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.